C. J. Goeman, “The Price Isn’t Right: Shareholder Proposals as Opportunities for Institutional Investors to Restore Firm Value and Reduce Pharmaceutical Prices”, CBLR, vol. 2017, no. 2, pp. 748–806, Aug. 2017.